PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Jul 7, 2023

SEC Form 4/A — Form 4/A

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-05-25

Reporting Person: Levinson Mitchell E. (Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-25	Common Stock	X	10935	$2.05	Acquired	68766	Direct
2023-05-25	Common Stock	X	814	$2.05	Acquired	4135	Indirect
2023-05-25	Common Stock	X	143	$2.05	Acquired	734	Indirect
2023-05-25	Common Stock	X	143	$2.05	Acquired	734	Indirect
2023-05-25	Common Stock	X	143	$2.05	Acquired	734	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-25	Warrant (right to buy)	$2.05	X	10935	Disposed	2027-06-09	Common Stock (10935)	Direct
2023-05-25	Warrant (right to buy)	$2.05	X	814	Disposed	2027-06-09	Common Stock (814)	Indirect
2023-05-25	Warrant (right to buy)	$2.05	X	143	Disposed	2027-06-09	Common Stock (143)	Indirect
2023-05-25	Warrant (right to buy)	$2.05	X	143	Disposed	2027-06-09	Common Stock (143)	Indirect
2023-05-25	Warrant (right to buy)	$2.05	X	143	Disposed	2027-06-09	Common Stock (143)	Indirect

Footnotes

F1: The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person.